Public Policy and Drug Producer Profits, Parts 1 and 2

From the Wall Street Journal we have a story tallying up the winners and losers from proposed health care reform. It looks like the drug makers are in for a bonanza, though things might not be so cheery for hospitals and insurers.

Meanwhile, the Department of Justice has decided against prosecuting growers and shops that sell state-sanctioned medical marijuana. Certainly, one of the big costs of being an illicit drug producer is the threat of legal sanctions, which is why organized crime often weighs in. With the liberalization of drug enforcement, will mom & pop producers run the Mexican cartels out of business?

Stay tuned.